SMC Global Securities Ltd Q1 FY27 Results

On the headline, SMC Global delivered what it promised: consolidated revenue ₹515.1 Cr is up 21.2% YoY, PAT grew 22.7% aligned with revenue, and the stock popped +6.8% in the five days after the result. But the three core businesses — broking, insurance, NBFC — told three different stories. Broking was steady; insurance was explosive but unprofitable; NBFC was a stumble. The consolidated number works. The path there is uneven.

Broking is the anchor. Revenue ₹316.3 Cr (+15.1% YoY), EBIT ₹74.3 Cr (+17.6% YoY), margin 23.5%. Management steered through a derivatives regulatory headwind — the segment faced restrictions on retail leverage over the past year — and pivoted to cash market business. Mutual fund AUM grew 11.5% QoQ to ₹4,787 Cr; the cash-market brokerage percentage rose from 45% to 55%; mark-to-fund book (MTF/T+5) jumped ₹140 Cr to ₹900 Cr. Client addition stayed healthy: 13.8 lakh accounts across the franchise. This is operating leverage at work — fixed-cost absorption on delivery and wealth, offsetting derivatives drag.

Insurance is the growth engine, but the profit disappeared. Gross premium ₹759 Cr (+44.4% YoY), a structural tailwind on household insurance penetration and non-life demand (90% of the book). Revenue hit ₹167.3 Cr. But EBIT was only ₹1.6 Cr — a margin of 0.96%, or roughly 1%. Management's explanation: investment in distribution headcount (corporate and life insurance ramp) and tech infrastructure for the reinsurance license upgrade. Prior quarter likely carried a 5–8% EBIT margin; this quarter's collapse is material. Management flagged 'operating leverage in future quarters,' but offered no timeline. If margin recovery slips past Q2 or Q3, insurance becomes a growth business that destroys profit.

NBFC missed guidance and the miss is real. AUM ₹1,025 Cr, down 8.3% QoQ from ₹1,118 Cr. Prior guidance: 15–20% AUM growth annually. Management blamed product repositioning: they discontinued LAP products (₹50 Cr AUM decline) and tightened unsecured business loans (₹40 Cr decline) to shift the book toward high-margin secured retail — Micro LAP, Gold Loan — now 75% of AUM. The explained decline is ~₹90 Cr; the residual ~₹3 Cr gap and the QoQ direction suggest demand softness beyond product mix. For FY27, management guided AUM closing at ₹1,250–1,300 Cr — a 7–27% recovery over three quarters. That wide band and the reset target (lower than prior multi-year expectations) signal caution.

The result was announced on July 26 (Sunday evening). The stock opened on July 29 with a +1.13% pop, with 77% delivery — a sign of institutional/informed accumulation on the first day. By day 3, the move had grown to +6.55%; by day 5, it held at +6.81%. The stock is now at ₹80.6, up from a pre-result close of ₹75.46. This is a modest but clean rally, not a euphoric breakout. The stock remains 15% below its all-time high of ₹94.9 and sits at its 52-week median, with normal volume. Institutional ownership is shallow: FII 2.39% (down 0.56 percentage points QoQ), DII near-zero, and promoter steady at 66.72%. The market bought the headline growth story, but the modest pop and institutional restraint suggest skepticism about the composition.

Consolidated PAT ₹36.7 Cr grew 22.7% YoY, tracking revenue growth 21.2% — the math is clean, no one-time items or MTM gains to reconcile. But the source matters. Standalone PAT (SMC Global parent) was ₹25.1 Cr, up only 9.6% YoY. The consolidated PAT of ₹36.7 Cr includes accretion from the insurance and NBFC subsidiaries. In other words: the parent's organic growth is single-digit; consolidated growth of 22.7% is driven by scale in the subsidiaries. This matters for profit sustainability. If insurance margins stay at 1% and NBFC AUM remains under pressure, the accretion will slow.

The EBITDA number also flags composition: EBITDA ₹107 Cr +6.9% YoY, vs. PAT +22.7% YoY. The gap is unusual — normally PAT grows slower than EBITDA when tax and interest are present. Here, consolidated PAT is growing faster than EBITDA, suggesting tax benefits or lower D&A from the mix. This is sustainable, but worth noting: if tax rates normalize or D&A rises, PAT growth could decelerate.

NBFC guidance downgrade. Prior guidance (from Q4 FY26 and earlier calls): 15–20% AUM growth annually. Q1 actual: -8.3% QoQ. Full-year FY27 target now ₹1,250–1,300 Cr (7–27% recovery over 3Q). This is a material reset, not a minor miss. The company explicitly blamed product repositioning (shift from LAP and unsecured to secured retail), but the scale of the miss and the wide-band FY27 target signal lost confidence in AUM traction. Management flagged a 1–2 year ramp before the 20–25% CAGR target materializes — a significant caveat.

Insurance guidance beat and overshoot. Prior guidance: 15% growth. Q1 actual: +44.4% YoY on gross premium ₹759 Cr. This is a structural win — household insurance penetration is accelerating, non-life is 90% of the book, and the regulatory upgrade to composite broker (for reinsurance license) opens new business. But management also signaled that margins are under pressure due to distribution capex, and deferred the timeline for operating leverage. No change to the 5-year strategy, but the profit inflection is now further out.

Broking neutral. No prior specific guidance; +15.1% YoY revenue growth is solid on a derivatives headwind. The cash market pivot (45%→55% brokerage %) and MTF ramp (₹140 Cr) are credible offsets. Stoxkart quadrupled revenue YoY to ₹20 Cr, adding a new subscription-model stream. No change in strategy, but execution is holding.